AstraZeneca Debate
Full Debate: Read Full DebateDepartment: Department for Science, Innovation & Technology
Tim Roca
Main Page: Tim Roca (Labour - Macclesfield)Department Debates - View all Tim Roca's debates with the Department for Science, Innovation & Technology
(1 day, 13 hours ago)
Commons ChamberRead Full debate Read Hansard Text Watch Debate Read Debate Ministerial Extracts
Urgent Questions are proposed each morning by backbench MPs, and up to two may be selected each day by the Speaker. Chosen Urgent Questions are announced 30 minutes before Parliament sits each day.
Each Urgent Question requires a Government Minister to give a response on the debate topic.
This information is provided by Parallel Parliament and does not comprise part of the offical record
Chris Bryant
The right hon. Lady puts it in a particular way, but it is not a way that is consonant with the facts. The fact is that this deal had not been signed or got over the line by the previous Government, who, as I have said, would quite often announce things and not actually deliver in the end. In spring 2024, the then Chancellor made it very clear in the documents that accompanied the Budget that all of this was contingent—his words, not mine—on due diligence. The then Government had not yet done the due diligence.
Tim Roca (Macclesfield) (Lab)
More than 5,000 people are employed at AstraZeneca’s Macclesfield campus, producing world-class medicines and contributing £1.8 billion in GVA and 1% of total UK exports. AstraZeneca has confirmed to me that the Speke decision does not impact Macclesfield, a site that it is committed to. Will the Minister confirm that the Government are committed to working with AZ so it continues to have a bright future in Macclesfield?
Chris Bryant
Yes, 100%. I know that my hon. Friend has visited AstraZeneca and spoken to it many times. He is absolutely right to note that there are, I think, 4,000 working at the Macclesfield site, and will continue to do so. I am sure that AstraZeneca has a very strong future in Macclesfield. Nothing in this decision changes that one iota.